• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. APTIMA SARS COV-2; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. APTIMA SARS COV-2; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Catalog Number PRD-06419
Device Problem Off-Label Use (1494)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/23/2022
Event Type  malfunction  
Manufacturer Narrative
Customer admitted to carelessness when preparing reagents and not checking the master lots of the refrigerated and room temperature components, which would be considered off-label use.Hologic technical support (ts) reviewed logs and found no instrument issues.Since this event was considered off package insert, ts was unable to provide review regarding reagent prep.Ts advised customer to discard the remaining of the prepared kits with mismatched master lots, as well as the unused components of these master lots.Customer understood and reported no further issues.As part of eua agreement, fda requires all aptima sars-cov-2 assay questioning results and false results (confirmed or not) complaints to be reported as malfunction mdr.
 
Event Description
Customer reported accidentally mixing sars-cov-2 tma reagents from different lots, which constitutes as off-label use.Customer used assay lot 315550 (room temperature reagents) with assay lot 317372 (refrigerated reagents) and ran patient samples on panther instrument sn (b)(4).The affected worklist, wl (b)(4), had 8 patient samples.Customer admitted the operator did not match the lots like they were supposed to and grabbed random boxes to mix, confirming this was an operator error.The information provided by the customer was insufficient to characterize any sample as a confirmed false result.Customer confirmed that the results were reported, but the lab supervisor decided to not amend results.There were no associated/reported adverse events or patient impact reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APTIMA SARS COV-2
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
Manufacturer (Section D)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer (Section G)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer Contact
kyleigh jacobs
10210 genetic center drive
san diego, CA 92121
8584108566
MDR Report Key15761567
MDR Text Key307889135
Report Number2024800-2022-01103
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberPRD-06419
Device Lot Number315550 / 317372
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/25/2022
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-